248 related articles for article (PubMed ID: 25947148)
1. Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein.
Rippa V; Santini L; Lo Surdo P; Cantini F; Veggi D; Gentile MA; Grassi E; Iannello G; Brunelli B; Ferlicca F; Palmieri E; Pallaoro M; Aricò B; Banci L; Pizza M; Scarselli M
Clin Vaccine Immunol; 2015 Jul; 22(7):769-77. PubMed ID: 25947148
[TBL] [Abstract][Full Text] [Related]
2. Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein.
Jongerius I; Lavender H; Tan L; Ruivo N; Exley RM; Caesar JJ; Lea SM; Johnson S; Tang CM
PLoS Pathog; 2013; 9(8):e1003528. PubMed ID: 23935503
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.
Beernink PT; Granoff DM
Infect Immun; 2008 Jun; 76(6):2568-75. PubMed ID: 18362128
[TBL] [Abstract][Full Text] [Related]
4. Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.
Brunelli B; Del Tordello E; Palumbo E; Biolchi A; Bambini S; Comanducci M; Muzzi A; Pizza M; Rappuoli R; Donnelly JJ; Giuliani MM; Serruto D
Vaccine; 2011 Jan; 29(5):1072-81. PubMed ID: 21130753
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
6. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.
Beernink PT; LoPasso C; Angiolillo A; Felici F; Granoff D
Mol Immunol; 2009 May; 46(8-9):1647-53. PubMed ID: 19286260
[TBL] [Abstract][Full Text] [Related]
7. Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.
van der Veen S; Johnson S; Jongerius I; Malik T; Genovese A; Santini L; Staunton D; Ufret-Vincenty RL; Pickering MC; Lea SM; Tang CM
Infect Immun; 2014 Mar; 82(3):1157-63. PubMed ID: 24379280
[TBL] [Abstract][Full Text] [Related]
8. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
Shaughnessy J; Lewis LA; Jarva H; Ram S
Infect Immun; 2009 May; 77(5):2094-103. PubMed ID: 19273554
[TBL] [Abstract][Full Text] [Related]
9. Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies.
Wang S; Xue J; Lu P; Ni C; Cheng H; Han R; van der Veen S
J Infect; 2018 Sep; 77(3):191-204. PubMed ID: 29902495
[TBL] [Abstract][Full Text] [Related]
10. Identification of epitopes recognized by monoclonal antibodies SM1 and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp.
Virji M; Heckels JE; Potts WJ; Hart CA; Saunders JR
J Gen Microbiol; 1989 Dec; 135(12):3239-51. PubMed ID: 2483993
[TBL] [Abstract][Full Text] [Related]
11. Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.
Piliou S; Farman TA; Marini A; Manoharan S; Mastroeni P
Vaccine; 2023 Dec; 41(52):7671-7681. PubMed ID: 38008665
[TBL] [Abstract][Full Text] [Related]
12. A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).
Koeberling O; Ispasanie E; Hauser J; Rossi O; Pluschke G; Caugant DA; Saul A; MacLennan CA
Vaccine; 2014 May; 32(23):2688-95. PubMed ID: 24704334
[TBL] [Abstract][Full Text] [Related]
13. A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial.
Richmond PC; Nissen MD; Marshall HS; Lambert SB; Roberton D; Gruber WC; Jones TR; Arora A
Vaccine; 2012 Sep; 30(43):6163-74. PubMed ID: 22871351
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
Baarda BI; Zielke RA; Holm AK; Sikora AE
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
[TBL] [Abstract][Full Text] [Related]
15. Rational design of a meningococcal antigen inducing broad protective immunity.
Scarselli M; Aricò B; Brunelli B; Savino S; Di Marcello F; Palumbo E; Veggi D; Ciucchi L; Cartocci E; Bottomley MJ; Malito E; Lo Surdo P; Comanducci M; Giuliani MM; Cantini F; Dragonetti S; Colaprico A; Doro F; Giannetti P; Pallaoro M; Brogioni B; Tontini M; Hilleringmann M; Nardi-Dei V; Banci L; Pizza M; Rappuoli R
Sci Transl Med; 2011 Jul; 3(91):91ra62. PubMed ID: 21753121
[TBL] [Abstract][Full Text] [Related]
16. Construction of recombinant neisserial Hsp60 proteins and mapping of antigenic domains.
Pannekoek Y; Dankert J; van Putten JP
Mol Microbiol; 1995 Jan; 15(2):277-85. PubMed ID: 7746149
[TBL] [Abstract][Full Text] [Related]
17. Reversible phase variation of expression of Neisseria meningitidis class 5 outer membrane proteins and their relationship to gonococcal proteins II.
Kawula TH; Aho EL; Barritt DS; Klapper DG; Cannon JG
Infect Immun; 1988 Feb; 56(2):380-6. PubMed ID: 3123389
[TBL] [Abstract][Full Text] [Related]
18. Potential large scale production of meningococcal vaccines by stable overexpression of fHbp in the rice seeds.
Ma J; Wang Y; Xu N; Jin L; Liu J; Xing S; Li X
Protein Expr Purif; 2018 Dec; 152():1-6. PubMed ID: 29953946
[TBL] [Abstract][Full Text] [Related]
19. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.
Malito E; Faleri A; Lo Surdo P; Veggi D; Maruggi G; Grassi E; Cartocci E; Bertoldi I; Genovese A; Santini L; Romagnoli G; Borgogni E; Brier S; Lo Passo C; Domina M; Castellino F; Felici F; van der Veen S; Johnson S; Lea SM; Tang CM; Pizza M; Savino S; Norais N; Rappuoli R; Bottomley MJ; Masignani V
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3304-9. PubMed ID: 23396847
[TBL] [Abstract][Full Text] [Related]
20. Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.
Granoff DM; Costa I; Konar M; Giuntini S; Van Rompay KK; Beernink PT
J Infect Dis; 2015 Sep; 212(5):784-92. PubMed ID: 25676468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
